USANA Health Sciences, Inc. (USNA)

Market Cap	342.95M
Revenue (ttm)	912.67M
Net Income (ttm)	16.99M
Shares Out	18.28M
EPS (ttm)	0.90
PE Ratio	20.87
Forward PE	9.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	83,807
Open	19.32
Previous Close	19.18
Day's Range	18.69 - 19.32
52-Week Range	18.69 - 41.84
Beta	0.65
Analysts	Hold
Price Target	36.00 (+91.9%)
Earnings Date	Oct 22, 2025

About USNA

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal...

• Industry: Packaged Foods
• Sector: Consumer Staples
• IPO Date: Jul 25, 1996
• Employees: 1,700
• Stock Exchange: NYSE
• Ticker Symbol: USNA
• Website: https://www.usana.com

Financial Performance

In 2024, USANA Health Sciences's revenue was $854.50 million, a decrease of -7.22% compared to the previous year's $921.01 million. Earnings were $42.03 million, a decrease of -34.11%.

Analyst Summary

According to one analyst, the rating for USNA stock is "Hold" and the 12-month stock price target is $36.0.

Price Target

$36.0

(91.90% upside)

Analyst Consensus: Hold